SerpinB1 is among the most efficient inhibitors of neutrophil serine proteases-NE, CG, and PR-3-and we investigated here its role in neutrophil development and homeostasis. We found that serpinB1 is expressed in all human bone marrow leukocytes, including stem and progenitor cells. Expression levels were highest in the neutrophil lineage and peaked at the promyelocyte stage, coincident with the production and packaging of the target proteases. Neutrophil numbers were decreased substantially in the bone marrow of serpinB1
Introduction
Neutrophils originate from hematopoietic stem cells via a granulocyte macrophage progenitor in the bone marrow [1] . These progenitors can differentiate into precursors of neutrophil-or monocyte/macrophage-committed lineages known as myeloblasts and promonocytes, respectively. Myeloblasts differentiate into promyelocytes and myelocytes, and these cells actively proliferate. After exiting the mitotic pool, myelocytes mature into metamyelocytes and then into band and mature neutrophils, with characteristic nuclear shape and segmentation. In steady-state hematopoiesis, the bone marrow holds considerably more mature neutrophils than the peripheral circulation [2, 3] . Unless recruited to extravascular sites, neutrophils remain in the blood for a few hours before being disposed of by macrophages in spleen, liver, and bone marrow. The reserve of bone marrow neutrophils can be rapidly called up to the blood circulation in response to mobilizing signals from the periphery. Bone marrow and circulating neutrophils are indeed a central component of the host defense against invading microbes. They are rapidly and massively recruited to sites of injury where they engulf cellular debris and pathogens, which are efficiently killed through the combined actions of the NADPH oxidase, antimicrobial peptides, and proteases [4, 5] . Therefore, availability and efficient mobilization of the bone marrow reserve of mature neutrophils are essential in host defense against infection.
NSPs are key elements of the innate immune arsenal against invading microbes. These molecules-NE, CG, and PR-3-are closely related cationic glycoproteins that are synthesized as proenzymes, undergo immediate post-translational activation by dipeptidylpeptidases [6] , and are stored in primary granules [7] . Detailed analysis of NSP expression has shown a tight transcriptional peak of expression in bone marrow promyelocytes that declines rapidly as neutrophils differentiate with no further mRNA expression of NSPs detected in postmitotic and mature neutrophils in the bone marrow or blood [8, 9] .
The NSP-mediated killing of microorganisms largely occurs in the phagosome after translocation of the oxidative machin-ery and the fusion with NSP-containing granules. Indeed, mice lacking NE, CG, or both fail to kill different bacterial and fungal pathogens, indicating overlapping and independent killing activities of NSPs against microorganisms [10 -12] . However, when NSPs are released in the extracellular milieu through degranulation and/or necrosis, their role is principally pathologic through direct proteolysis of matrix proteins, antimicrobial defense molecules, as well as cytokines and receptors. In addition, NSPs propagate inflammation by enhancing production of inflammatory mediators by lung macrophages and epithelial cells. Accordingly, mice deficient in NE, CG, and PR-3 are protected against LPS-induced systemic shock, antibodyinduced arthritis, and skin inflammation [6, 13] .
Mature neutrophils thus contain high NSP concentrations but lack transcriptional and translational mechanisms for de novo NSP production. As a result, the levels of NSPs at inflammatory sites are correlated directly with neutrophil recruitment and degranulation, and specific inhibitors are essential to regulation of their functions. Prominent among NSP inhibitors are ␣1-antitrypsin (encoded by the gene SERPINA1) [14, 15] and SERPINB1 (also called MNEi) [16, 17] . Both efficiently inhibit the three NSPs using a conformational change suicide mechanism, classical for the serpin superfamily, which irreversibly traps and inactivates the target protease [18] . Whereas ␣1-antitrypsin is a secreted protein produced in the liver and found at high levels in plasma, serpinB1 is a member of the clade B family of serpins that have intracellular localization [19] . Although it has been long established that ␣1-antitrypsin deficiency leads to the development of pulmonary emphysema, individuals with low levels or absent ␣1-antitrypsin do not have increased risk of infection. In contrast, we demonstrated recently that serpinB1 plays a key protective role in regulating NSPs during lung infection [20] . SerpinB1 Ϫ/Ϫ mice failed to clear Pseudomonas aeruginosa lung infection, in part, as a result of increased death of neutrophils recruited to the lungs. Here, we found that serpinB1 Ϫ/Ϫ mice have a profound reduction in their bone marrow neutrophil reserve, and we report the effect of serpinB1 Ϫ/Ϫ on the different stages of neutrophil development and homeostasis.
MATERIALS AND METHODS

Human samples
Bone marrow samples consisted of aliquots of specimens that remained on completion of studies conducted at Harvest Technologies (Plymouth, MA, USA). Bone marrow staining was performed 24 h after collection.
Mice
SerpinB1
Ϫ/Ϫ mice were generated in 129S6/SvEvTac (129S6), as described previously [20] . In some experiments, serpinB1 Ϫ/Ϫ mice, backcrossed in C57BL/6 background for 10 generations, were also used. To increase the quality of the backcrossing, serpinB1 ϩ/Ϫ breeders were further selected based on the polymorphic PCR markers D13Mit117 and D13Mit16, which differ in the two strains, and thus, the portion of mouse chromosome 13 belonging to the 129S6 strain has been reduced to less than 3-4 cM on each side of the serpinB1 locus. Animal studies were approved by the Animal Care and Use Committee of the Immune Disease Institute (Boston, MA, USA) and by the Cantonal Veterinary Office of Bern (Switzerland).
Mouse bone marrow and blood collection
Bone marrow cells were isolated by flushing femurs with 2-4 ml PBS or IMDM per femur using a 31-gauge needle. Blood was collected from the retro-orbital sinus of sedated mice using heparinized microhematocrit tubes. Cell counts in blood, isolated bone marrow, and BAL were measured on a Ac·T diff2 counter (Beckman Coulter, Brea, CA, USA).
Myelosuppression and model of acute lung injury
Myelosuppression was induced in mice with a single i.p. injection of CY (200 mg/kg) as described previously [21] . Acute lung injury and recruitment of neutrophils to the alveolar space were induced by intranasal instillation of LPS solution (P. aeruginosa, 0.5 mg/ml in PBS; 10 g/mouse), as described previously [20] . Twenty-four hours after challenge, bone marrow cells and BAL cells were harvested from mice killed by an overdose of isoflurane. Tracheas were canulated with an 18-gauge angiocatheter, and lungs were lavaged five times with 0.8 ml cold PBS. Analysis of BAL cells was performed on cells pooled from the five washes.
Colony-forming cell assays
Bone marrow cells were isolated from femurs as described above, and 2 ϫ 10 5 cells were plated in 35 mm dishes in duplicate in semisolid methylcellulose medium containing stem cell factor, IL-3, IL-6, and EPO, following the manufacturer's instructions (MethoCult M3434, Stem Cell Technologies, Vancouver, BC, Canada). After 7 days in culture, colonies were identified by morphology and counted independently by two investigators. CFU-G colony core size was measured after 9 days.
Flow cytometry and sorting
Whole blood, bone marrow, and BAL cells were stained with fluorochromelabeled mAb or biotinylated mAb, followed by fluorescently conjugated streptavidin (BioLegend, San Diego, CA, USA; and BD Biosciences, San Diego, CA, USA). Intracellular staining for human SERPINB1 and mouse Ki-67 was performed after surface-staining, followed by permeabilization (CytoFix/CytoPerm). To generate anti-human SERPINB1 mAb (clone ELA-5), mice were immunized with recombinant SERPINB1 from Sf9 insect cells, which was partially purified by Q-Sepharose chromatography [22] . Intranuclear detection of EdU integrated into genomic DNA was performed with an AlexaFluor647 azide following instructions from the manufacturer (Invitrogen, Carlsbad, CA, USA) [23] . Flow cytometry data were acquired on FACSCalibur or FACSCanto II cytometers (BD Biosciences). The data were analyzed and presented using FlowJo software (Tree Star, Ashland, OR, USA). PMNs (CD45 
Western blotting
Cell-sorted and whole bone marrow cell lysates were resolved by SDS-PAGE under reducing conditions and immunoblotted using rabbit antiserum to SERPINB1, MMP-9 (U.S. Biologicalsm Hialeah, FL, USA), Mcl-1, A1/Bfl-1, and Bcl-X L (Cell Signaling Technology, Beverly, MA, USA), and goat polyclonal antibody to PR-3 (P-20, Santa Cruz). Blots were stripped and restained with rabbit anti-␤-actin antibody (Cell Signaling Technology).
RNA isolation and real-time qRT-PCR
Total RNA was isolated from flow cytometry-sorted cells using the RNABee (AMS Biotechnology, UK) treated with DNase I (Ambion, Austin, TX, USA) and reverse-transcribed using SuperScript III First-Strand (Invitrogen). qRT-PCR of mouse serpinb1 was performed in triplicate on a ABI PRISM 7900HT (Applied Biosystems, Foster City, CA, USA) using specific primers: 5Ј-CATCTTCTTCTCTCCCTTCAGC-3Ј and 5Ј-GAGTGTGAGATGCTCCACGT-3Ј.
SerpinB1 mRNA levels were expressed relative to endogenous control S16 ribosomal protein mRNA using the following primers: 5Ј-GATATTCGGGT-CCGTGTGA-3Ј and 5Ј-TTGAGATGGACTGTCGGATG-3Ј.
NE activity assay
NE enzymatic activity in bone marrow fluid was measured in a standard colorimetric assay in 20 mM Tris, pH 7.4, 500 mM NaCl, 0.05% Tween-20, and 4 mM DTT using N-methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide (Sigma-Aldrich, St. Louis, MO, USA) as substrate. Human sputum elastase (Elastin Products, Owensville, MO, USA) was used as a standard. Bone marrow fluid was collected by flushing each femur with 0.5 ml PBS. Cells were centrifuged, and the supernatant was aliquoted and stored frozen until tested.
ELISA
Concentrations of cytokines (G-CSF) in serum and/or bone marrow fluid were measured in duplicate by ELISA (R&D Systems, Minneapolis, MN, USA; and BioLegend).
In vitro assay for neutrophil survival
Bone marrow neutrophils were purified using a Percoll gradient followed by B cell depletion (CD45R B220; Dynal, Oslo, Norway). Neutrophil purity was evaluated by flow cytometry and was 75-90%. Suspensions of 2 ϫ 10 6 neutrophils/ml were cultured for 16 h in DMEM containing 1% FCS. Apoptosis and necrosis were assessed by simultaneous staining with Ly-6G, 7-AAD, and annexin V.
Statistical analysis
All analyses were performed using Prism software (GraphPad, San Diego, CA, USA). All data were expressed as mean Ϯ sem and were analyzed by the unpaired Student's t-test or two-way ANOVA with Bonferroni's post-hoc test as required. P Ͻ 0.05 was considered statistically significant.
RESULTS
SerpinB1
؊/؊ PMN reserve is reduced in steady-state and depleted during inflammatory injury
To investigate a role for serpinB1 in neutrophil development and homeostasis, bone marrow cells were isolated from serpinB1 Ϫ/Ϫ and WT mice. Total nucleated cell counts were significantly lower in serpinB1 Ϫ/Ϫ bone marrow in mice. Analysis of the leukocyte composition of the bone marrow of WT and serpinB1 Ϫ/Ϫ mice was performed by flow cytometry to identify PMN, myelocytes, promonocytes/monocytes, and B cells (Fig. 1A) . Relative and absolute PMN numbers were reduced significantly in bone marrow of serpinB1 Ϫ/Ϫ mice compared with age-matched WT mice ( Fig. 1B and C) . Absolute numbers of myelocytes and monocytic cells were reduced to a smaller extent than mature PMNs, whereas B cells and lineage-negative cells (CD45 ϩ lin neg ; including hematopoietic progenitors) were not different between the genotypes. The bone marrow neutropenia was largely responsible for the reduction of total nucleated cell counts in the bone marrow of serpinB1 Ϫ/Ϫ mice. These results were replicated in serpinB1 Ϫ/Ϫ mice in two genetic backgrounds (129S6 in Fig. 1B and C and C57BL/6 in Fig. 2A ), demonstrating that the steady-state defect in the PMN reserve is highly penetrant. Of note, percent and absolute numbers of neutrophils in the blood were not significantly different in WT (9.4Ϯ1.0%; 0.75Ϯ0.09ϫ10 6 /ml; nϭ10) and serpinB1 Ϫ/Ϫ (9.5Ϯ1.1%; 0.56Ϯ0.09ϫ10 6 /ml; nϭ10) mice. The reserve of mature neutrophils in the bone marrow is readily mobilizable at the onset of an acute injury. Depletion of this neutrophil reserve, or storage pool, is frequently observed in neonates with sepsis, who fail to clear bacterial infection [24] . To evaluate whether the reduced PMN reserve in 
serpinB1
Ϫ/Ϫ mice has physiological consequences during infection or inflammation, acute lung injury was induced in WT and serpinB1 Ϫ/Ϫ mice. Twenty-four hours after intranasal LPS treatment, PMNs were massively mobilized to the lungs ( Fig. 2A and  B) , and PMN numbers were decreased significantly in bone marrow of WT and serpinB1 Ϫ/Ϫ mice. In particular, we observed almost total depletion of the PMN reserve in serpinB1 Ϫ/Ϫ bone marrow (Fig. 2B) , indicating that the reduced PMN reserve may contribute to the reduced bacterial clearance reported previously in serpinB1 Ϫ/Ϫ mice [20] . As neutrophils were mobilized in response to LPS challenge, the proportion and absolute numbers of myelocytes increased significantly in WT and serpinB1 Ϫ/Ϫ bone marrow. In steady-state, the ratio of myelocytes to neutrophils was greater in serpinB1 Ϫ/Ϫ mice (0.35Ϯ0.02) compared with WT mice (0.12Ϯ0.01), reflecting reduced, mature neutrophil numbers. This ratio was increased significantly 24 h after LPS challenge in both genotypes and was also significantly higher in serpinB1 Ϫ/Ϫ mice (serpinB1 Ϫ/Ϫ , 0.96Ϯ0.09; WT, 0.35Ϯ0.07; PϽ0.001).
SERPINB1 levels peak in human bone marrow promyelocytes
We next examined whether SERPINB1 expression is regulated during myeloid cell differentiation in the bone marrow. For this analysis, we used bone marrow cells obtained from human donors, where the stages of myeloid development have been examined in great detail. We took advantage of an analytical flow system based on expression level of CD45 and granularity designed to identify developing human myeloid cells [25] and used to study cells of patients with myelodysplastic syndromes [26] (Fig. 3A) . In human bone marrow, SERPINB1 was present in all CD45 ϩ populations. Expression levels were highest in the neutrophil lineage, intermediate in monocytic, and lowest in lymphocytic lineages (Fig. 3B ). Blast cells, including CD34 ϩ stem cells, had a broad expression level in the low-intermediate range. Within the neutrophil lineage, SERPINB1 expression was highest in promyelocytes (SSC hi CD45 dim ), where the MFI was 25-fold increased compared with blasts and progenitor cells. This increase is likely important, as it coincides with the synthesis of target proteases and their storage in primary azurophil granules, which only occurs at the promyelocyte stage [8] . As cells proliferate during approximately three cycles of mitosis at the myelocyte stage [27] , differentiate, and mature, SERPINB1 levels decrease slightly to reach the expression levels of circulating neutrophils. In parallel, the primary granules laid down at the promyelocyte stage are divided between daughter cells. These findings indicate that SERPINB1 expression is found in human stem and noncommitted precursor cells and that high levels of SERPINB1 are induced early during granulopoiesis in concert with target NSP production and remain high in mature neutrophils compared with other lineages. A similarly high induction of serpinB1 expression in the early stages of granulopoiesis was also observed in WT mouse bone marrow. Myelocytes (SSC hi CD11b ϩ Ly-6G neg ), mature neutrophils (CD11b ϩ Ly6G hi ), and B cells (CD19 ϩ ) were sorted by flow cytometry, cell purity was assessed on cytospins (Supplemental Fig. 1) , and serpinb1 mRNA expression was measured by qRT-PCR. Compared with B cells, serpinb1 mRNA expression levels were 18-and 33-fold higher in myelocytes and mature neutrophils, respectively.
Myeloid and granulocyte lineage development potential
To evaluate the effect of serpinB1 Ϫ/Ϫ on early myeloid and/or granulocyte progenitors, bone marrow cells of WT and serpinB1 Ϫ/Ϫ mice were cultured in vitro in a semi-solid matrix to quantify myeloid CFUs. In this assay, each progenitor cell produces a colony-comprising cell of a single or limited number of lineages, depending on its initial differentiation status, including multipotential (granulocyte-erythrocytemacrophage-megakaryocyte), granulocyte-macrophage, granulocyte, and macrophage progenitors. The frequency of CFU subsets was not significantly different in culture of serpinB1 Ϫ/Ϫ and WT bone marrow progenitors (Fig. 3C) . The absolute CFU counts were also similar in serpinB1 Ϫ/Ϫ and WT mice with a small but not significant increase in CFU-G of serpinB1 Ϫ/Ϫ mice (Fig. 3D) . These findings indicate that the number of myeloid and granulocyte progenitors, which are committed to the granulocyte lineage but do not express NSPs, is not reduced in the bone marrow of serpinB1 Ϫ/Ϫ mice and that these progenitors can differentiate into colonies when given appropriate growth factor signals in vitro. Similar size and morphology of CFU-G colonies were obtained from bone marrow culture of serpinB1 Ϫ/Ϫ and WT mice (Supplemental Fig. 2) .
A central regulator of neutrophil development and survival in vivo is G-CSF. As G-CSF is proteolytically sensitive to NE, we tested whether a decrease of G-CSF could contribute to the reduced number of PMNs in serpinB1 Ϫ/Ϫ bone marrow. Interestingly, serum G-CSF in steady-state was increased fourfold in serpinB1 Ϫ/Ϫ compared with WT mice (Fig. 3E) . Therefore, a lack of G-CSF is likely not the cause of the serpinB1 Ϫ/Ϫ bone marrow neutropenia. Taken together, these results suggest that myeloid progenitor development and granulopoiesis, rather than being blocked, are favored and possibly enhanced in serpinB1 Ϫ/Ϫ mice. The small increase of granulocyte progenitors (CFU-G) may thus reflect a feedback response to increased G-CSF production.
Neutrophil homeostasis in bone marrow and blood
Progenitors committed to the neutrophil lineage undergo a rapid and vast expansion at the promyelocyte/myelocyte stages, which correspond to the mitotic pool, in opposition to the maturation pool, where cells do not proliferate anymore and mature into metamyelocytes, band, and mature PMNs. We evaluated the proliferative status of neutrophil and monocyte lineages using the mitotic marker Ki-67, which is expressed during the G 1 -S-G 2 -M phases of the cell cycle but not in quiescent G 0 cells. Absolute numbers and percentage of Ki-67 ϩ myelocytes (CD11b ϩ Ly6G neg SSC hi ) were increased significantly in serpinB1 Ϫ/Ϫ bone marrow ( Fig. 4A and B) , whereas the absolute numbers of Ki-67 ϩ PMNs (CD11b ϩ Ly6G ϩ ) and monocytic (CD11b ϩ Ly6G neg SSC low ) cells were not different between the two genotypes. Thus, the reduced number of mature PMN in serpinB1 Ϫ/Ϫ marrow is paradoxically associated with increased numbers of cycling neutrophil precursor cells.
To directly assess PMN output in vivo, blood and bone marrow of WT and serpinB1 Ϫ/Ϫ mice were examined after a pulse of EdU, a thymidine analog that incorporates in cells of the mitotic pool during DNA synthesis [23] . The accumulation of EdU ϩ PMNs in the bone marrow was significantly blunted in serpinB1 Ϫ/Ϫ mice with significantly reduced numbers compared with WT mice on Day 2 (Fig. 4C) . The number of EdU ϩ PMNs remained lower in serpinB1 Ϫ/Ϫ compared with WT bone marrow on subsequent days, as both genotypes returned to baseline by Day 5 (Fig. 4C) . The data for Day 1 were particularly informative. On this initial production day, the absolute numbers of EdU ϩ PMNs were similar (approximately 0.5ϫ10 6 EdU ϩ PMNs/femur) in mice of the two genotypes, but because of the reduced total PMN numbers in the bone marrow, this represented 17% of the bone marrow PMNs for the WT mice but 30% for serpinB1 Ϫ/Ϫ mice (Supplemental Fig. 3) , suggesting loss of the most mature cells, which were EdU neg on Day 1. In contrast, the kinetics of myeloid/monocytic precursor cell (CD11b ϩ Ly-6G neg ) biogenesis was not different between the two genotypes (Fig. 4D) . These findings indicate that the initial production of mature PMNs is comparable in WT and serpinB1 Ϫ/Ϫ mice and that the deficit of bone marrow PMN in serpinB1 Ϫ/Ϫ mice is largely restricted to postmitotic PMNs.
The content of EdU ϩ PMNs in blood was quantified over time to investigate release of neutrophils. The number of EdU ϩ PMNs in blood was significantly higher in serpinB1 ϩ Ly-6G neg ; including myelocytes and CD11b ϩ monocytes) in bone marrow. Absolute numbers of EdU ϩ blood PMNs (CD11b ϩ Ly-6G ϩ ) (E) and monocytes (CD11b ϩ Ly-6G neg ) (F) in the same animals. Pooled data from two independent experiments (meanϮsem; nϭ4/ time-point; **PϽ0.01; ***PϽ0.001). For all panels, WT and serpinB1 Ϫ/Ϫ are shown as black and white symbols, respectively. mice on Day 3 compared with WT mice (Fig. 4E) . Thus, there is a greater flux of PMNs in blood of serpinB1 Ϫ/Ϫ mice compared with WT mice. Importantly, the relatively earlier egress of serpinB1 Ϫ/Ϫ PMNs from the bone marrow to the circulation is not the only cause of the reduced bone marrow reserve, as EdU ϩ PMNs were not detected in blood until Day 3 after the EdU pulse, whereas the bone marrow deficit was noted on Day 2. In contrast, the kinetics of EdU ϩ blood monocytes was not different in the two genotypes (Fig. 4F) . Overall, serpinB1 Ϫ/Ϫ neutrophils have a reduced half-life as a result of an increased loss of mature PMNs within the bone marrow that results in bone marrow neutropenia associated with an early egress of neutrophils to the circulation.
Increased apoptosis and necrosis of serpinB1
؊/؊ bone marrow neutrophils
We next evaluated survival properties of serpinB1 Ϫ/Ϫ PMNs within the bone marrow. We measured cell death in freshly isolated and in in vitro-cultured bone marrow PMNs. No difference in apoptosis and necrosis was observed in freshly isolated bone marrow cells from mice of the two genotypes with Ͼ95% viability. However, after overnight culture, apoptosis and secondary necrosis were increased significantly in purified serpinB1 Ϫ/Ϫ PMNs compared with WT PMNs (Fig. 5A and B) .
Neutrophil survival is dependent on high levels of antiapoptotic members of the Bcl-2 family proteins. Purified bone marrow PMNs were analyzed by Western blot probed with antibodies against Mcl-1, Bcl-X L , and A1 (Fig. 5C ). Bcl-X L and A1 were not different in PMN lysates of both genotypes, whereas Mcl-1 was increased in PMN lysates of serpinB1 Ϫ/Ϫ mice. High Mcl-1 levels in serpinB1 Ϫ/Ϫ PMNs suggest a compensatory feedback mechanism induced by high G-CSF or alternatively, may result from the selected survival of a subset of high Mcl-1 expressing PMNs. Lysates from simultaneously sorted B cells showed no difference between genotypes in Mcl-1 and Bcl-X L levels, whereas A1 levels were reduced in B cells of serpinB1 Ϫ/Ϫ mice compared with those of WT mice (Supplemental Fig. 4) . Levels of PR-3 and MMP-9 (neutrophil gelatinase) were not different in PMNs isolated from mice of the two genotypes (Fig. 5C ), indicating that mature neutrophils in serpinB1 Ϫ/Ϫ marrow undergo normal terminal differentiation. A block in neutrophil differentiation and/or maturation would have resulted in increased PR-3 and reduced MMP-9 levels in serpinB1
PMNs, as PR-3 is expressed early at the promyelocyte stage, whereas MMP-9 is synthesized late, mainly in band and segmented neutrophils [28] . We had shown previously that NE and CG are found at normal levels in neutrophils of serpinB1 Ϫ/Ϫ mice [20] . These findings indicate that there is no maturation arrest in serpinB1 Ϫ/Ϫ PMNs.
Myelosuppression and granulocytic regeneration
NSP activity has been shown to be transiently increased in the bone marrow microenvironment after stimulation with G-CSF or IL-8 or in response to myelosuppresive agents, resulting in the cleavage of key adhesion molecules [21, 29, 30] . We used CY to induce myelosuppression in mice to investigate the role of serpinB1 in the subsequent emergency granulopoiesis mediated by G-CSF. Before CY treatment, absolute numbers of blood PMNs were not significantly different between mice of the two genotypes. CY-induced cytotoxicity of hematopoietic precursor cells resulted in a profound and transient myelosuppression in serpinB1 Ϫ/Ϫ and WT mice. A strong blood neutrophilia was observed in both genotypes on Days 1 and 2 after CY, and serpinB1 Ϫ/Ϫ PMNs disappeared from the circulation at a faster rate, as shown by reduced numbers and lower frequency of PMNs in blood on Day 3 ( Fig. 6A and B) . Neutropenia was complete in both genotypes 4 days after CY. During the recovery phase, the increase in blood PMN counts was comparable in WT and serpinB1 Ϫ/Ϫ mice on Days 6, 10, and 14 after CY (Fig. 6A and B) , indicating that neutrophil progenitors in serpinB1 Ϫ/Ϫ and WT mice were equally responsive to this emergency granulopoietic challenge. The transient increase in serum G-CSF in response to CY was higher in serpinB1 Ϫ/Ϫ mice, and by Day 14, G-CSF levels returned to baseline, maintaining a higher concentration in serpinB1 Ϫ/Ϫ mice (Fig. 6C) . In CY-treated mice, an increase in extracellular NE activity in bone marrow fluid at Day 6 was observed in WT mice, as described previously [21] . A similar increase in extracellular NE was found in bone marrow fluid of serpinB1 Ϫ/Ϫ mice (Fig. 6D) . Moreover, except for the CY-induced elevation, baseline levels of free NE activity were not elevated in the serpinB1 Ϫ/Ϫ bone marrow. These findings indicate that ser- pinB1 function is dispensable in regulating the CY-induced flux of extracellular NE and is dispensable for the G-CSFdriven emergency granulopoietic response following the neutropenia. Overall, serpinB1 Ϫ/Ϫ results in a faster PMN depletion and blood neutropenia following CY-induced mobilization of the bone marrow pool. Emergency granulopoiesis following the neutropenia was however normal.
DISCUSSION
SerpinB1 is one of the most efficient inhibitors of NSPs [22, 31, 32] and is highly conserved in all vertebrates [33, 34] . We have shown here that serpinB1 is required to maintain a healthy reserve of mature neutrophils in the bone marrow. In serpinB1 Ϫ/Ϫ mice, neutrophil mobilization from the bone marrow led to the depletion of the reserve after inflammatory injury. We have shown previously that serpinB1 Ϫ/Ϫ mice fail to clear lung infection with P. aeruginosa and that this defect is caused in part by increased death of lung-recruited neutrophils and by increased NSP activity in the lungs [20] . Our current findings suggest that the reduced pool of mature PMNs is an additional contributor leading to defective innate immune response to infection in serpinB1 Ϫ/Ϫ mice. Furthermore, serpinB1
Ϫ/Ϫ mice reached a neutropenic state more rapidly after chemotherapy. This finding may be relevant in evaluating risks of FN in candidate patients for chemotherapy. FN is a severe and common complication of cancer chemotherapy that is characterized by opportunistic bacterial and fungal infections as a result of prolonged, low neutrophil blood counts. Preventive treatment with G-CSF can significantly reduce the incidence of FN, but a systematic use of this preventive treatment is not feasible because of the costs. Identifying the patients at risk of developing FN will help maximize benefits and minimize costs [35] . Our results suggest that testing for serpinB1 levels and genetic polymorphisms in circulating cells may help identify such patients. The reduction in the bone marrow neutrophil reserve reported here in serpinB1 Ϫ/Ϫ mice is highly significant, reproducible in two genetic backgrounds, and comparable in magnitude to the depletion observed in G-CSF-deficient mice, where the mature neutrophil reserve is reduced by 50% [36] . However, the mechanism leading to the deficient PMN reserve in serpinB1 Ϫ/Ϫ mice differs from G-CSF deficiency and from currently described neutropenic diseases. Our results indicate that there are no defects of CFU-GM and CFU-G progenitor numbers in serpinB1 Ϫ/Ϫ bone marrow in contrast to what is observed when G-CSF signaling is impaired [36 -38] . No maturation arrest was observed in serpinB1 Ϫ/Ϫ bone marrow neutrophils, which expressed normal levels of PR-3 and MMP-9, a protein expressed late in neutrophil maturation [28] . Therefore, the neutropenia in serpinB1 Ϫ/Ϫ mice differs from that observed in patients with severe congenital neutropenia and cyclic neutropenia, which are characterized by a maturation arrest at the promyelocyte/myelocyte stage [39 -42] . The vast majority of neutropenic syndromes are responsive to G-CSF therapy, which overcomes maturation arrest and dramatically reduces risks of recurrent infection [43] [44] [45] . In serpinB1 Ϫ/Ϫ mice, G-CSF levels in serum are increased compared with WT mice in steady-state. Following myelosuppression, serpinB1 Ϫ/Ϫ and WT mice produced high levels of G-CSF, followed by a transient neutrophilia. Thus, the bone marrow of serpinB1 Ϫ/Ϫ mice is responsive to the effects of G-CSF. Overall, these findings indicate that SERPINB1 Ϫ/Ϫ may define a novel form of bone marrow neutropenia and that genetic testing for SERPINB1 mutations in patients with transient neutropenia or susceptibility to infection should be explored. SERPINB1 protein expression was detected in all bone marrow cells, and protein levels were greater in the neutrophil lineage by at least one order of magnitude compared with other lineages. Importantly, we found that SERPINB1 protein expression precedes commitment to the neutrophil lineage. Furthermore, during neutrophil bone marrow development, a considerable induction of SERPINB1 expression occurred at the differentiation from myeloblast to promyelocyte, which coincides with the expression of the target granule proteases (NE, CG, and PR-3) [8, 9] . Previous reports have indicated that SERPINB1 mRNA was expressed early in neutrophil development [46] and that the SERPINB1 transcription profile was similar to that of primary granule proteins [9] . The absence of defects in serpinB1 Ϫ/Ϫ bone marrow progenitors, which do not contain NSPs, and the correlation between high levels of NSPs and serpinB1 in neutrophils suggest that serpinB1 regulates a proteolytic event important for neutrophil survival. This proposition would fit the broad hypothesis that clade B serpins protect against misdirected granule proteases and/or protect bystander cells during inflammation [47] and are best-exemplified in the cytoprotective function of SerpinB9 (human PI-9, murine serine PI-6), an inhibitor of the apoptosis-inducer granzyme B [48 -50] . Here, we found a homeostatic role for serpinB1 in neutrophils in the absence of inflammation or infection through survival of mature neutrophils within the bone marrow. Western blot analysis of antiapoptotic Bcl-2 family proteins in purified bone marrow neutrophils revealed that the loss of serpinB1 Ϫ/Ϫ neutrophils was not a result of proteolytic cleavage of Mcl-1, Bcl-X L , and A1/Bfl-1, three key antiapoptotic proteins in neutrophils [51] . On the contrary, it appeared that Mcl-1 was up-regulated in serpinB1 Ϫ/Ϫ neutrophils, suggesting a compensatory mechanism linked to increased G-CSF levels. Further work is ongoing to define the NSP(s) involved in this process and the molecular targets of such a pathway that may be key to understanding neutrophil turnover. ␣1-Antitrypsin (serpinA1), the well-characterized plasma inhibitor of NSPs, has been shown to regulate extracellular proteases, particularly NE, within the bone marrow of mice treated with CY, G-CSF, and IL-8 [52, 53] . The peak in free NE in the bone marrow fluid observed on Day 6 after CY treatment has been attributed to reduced production of serpinA1 in the bone marrow. Free NE activity in the bone marrow was identical in serpinB1 Ϫ/Ϫ and WT mice after CY treatment, indicating that serpinB1 is not required in controlling NE during CY-induced myelosuppression. These findings suggest that the two serpins, which have nearly identical inhibitory properties [32] , have distinct and complementary functions in regulating bone marrow neutrophils, where serpinB1 is required for maintaining the mobilizable reserve needed for immediate responses to infection or injury but is dispensible for the release of neutrophils in emergency granulopoiesis, where ␣1-antitrypsin plays an important role.
In conclusion, our study demonstrates that serpinB1 Ϫ/Ϫ results in a novel form of neutropenia characterized by reduced survival of mature, postmitotic neutrophils within the bone marrow, and thus, serpinB1 is essential to maintain a healthy PMN bone marrow pool that is needed in acute inflammatory responses. 
